Code | 1557D | ||||||||||
MA number | EU/1/18/1293/004 | ||||||||||
Product Form: | sol inj 1x1 ml/140 mg (striek.inj.skl.v napl.pere) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
Therapeutic Class: | 33 - ANTIMIGRAENICA,ANTISEROTONICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | pre-filled syringe | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 26.07.2018 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 03.03.2023 |